Analysis of factor V in zebrafish demonstrates minimal levels needed for hemostasis and risk stratifies human variants

In humans, coagulation factor V (F5) deficiency is a rare, clinically heterogeneous bleeding disorder, suggesting that genetic modifiers may contribute to disease expressivity. Complete loss of mouse F5 results in early lethality. Zebrafish possess many distinct advantages including high fecundity, optical clarity, external development, and homology with the mammalian hemostatic system, features that make it ideal for genetic studies. Our aim was to study the role of F5 in zebrafish through targeted mutagenesis, and apply the model to the study of human F5 variants. CRISPR-mediated genome editing of the zebrafish f5 locus was performed, generating mutants homozygous for a 49 base pair deletion in exon 4. Thrombus formation secondary to vascular endothelial injury was absent in f5-/- mutant embryos and larvae. Despite this severe hemostatic defect, homozygous mutants survived before succumbing to severe hemorrhage in adulthood. Human F5 variants of uncertain significance from patients with F5 deficiency were evaluated, and the causative mutations identified and stratified by their ability to restore thrombus formation in larvae. Analysis of these novel mutations demonstrates variable residual F5 function, with minimal activity being required to restore hemostasis. This in vivo evaluation may be beneficial for patients whose factor activity levels lack correlation with bleeding symptomatology. Furthermore, homozygous mutant embryos tolerate what is a severe and lethal defect in mammals, suggesting the possibility of species-specific factors enabling survival, and allowing further study not possible in the mouse. Identification of these factors or other genetic modifiers could lead to novel therapeutic modalities. Key Points F5 mutant fish embryos tolerate symptoms lethal in mammals but succumb to bleeding in adulthood Analysis of human variants demonstrate that all have some residual function and that minimal F5 activity is required to restore hemostasis

[1]  P. Simioni,et al.  “In vitro” correction of the severe factor V deficiency‐related coagulopathy by a novel plasma‐derived factor V concentrate , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  J. Joung,et al.  Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway. , 2017, Blood.

[3]  N. Mackman,et al.  Animal Models of Thrombosis From Zebrafish to Nonhuman Primates: Use in the Elucidation of New Pathologic Pathways and the Development of Antithrombotic Drugs. , 2016, Circulation research.

[4]  J. Shavit,et al.  Simple and rapid quantification of thrombocytes in zebrafish larvae. , 2015, Zebrafish.

[5]  J. Shavit,et al.  Zebrafish as a model system for the study of hemostasis and thrombosis , 2014, Current opinion in hematology.

[6]  Morgan L. Maeder,et al.  Targeted mutagenesis of zebrafish antithrombin III triggers disseminated intravascular coagulation and thrombosis, revealing insight into function. , 2014, Blood.

[7]  M. Neerman-Arbez,et al.  Targeted mutation of zebrafish fga models human congenital afibrinogenemia. , 2014, Blood.

[8]  P. Ingham,et al.  A method for high-throughput PCR-based genotyping of larval zebrafish tail biopsies. , 2013, BioTechniques.

[9]  Andy H. Vo,et al.  Loss of Fibrinogen in Zebrafish Results in Symptoms Consistent with Human Hypofibrinogenemia , 2013, PloS one.

[10]  R. Camire,et al.  Parahemophilia: New Insights into Factor V Deficiency , 2013, Seminars in Thrombosis & Hemostasis.

[11]  Jeffry D. Sander,et al.  Heritable and Precise Zebrafish Genome Editing Using a CRISPR-Cas System , 2013, PloS one.

[12]  Anton J. Enright,et al.  The zebrafish reference genome sequence and its relationship to the human genome , 2013, Nature.

[13]  Jeffry D. Sander,et al.  Efficient In Vivo Genome Editing Using RNA-Guided Nucleases , 2013, Nature Biotechnology.

[14]  Andy H. Vo,et al.  Characterization of Zebrafish von Willebrand Factor Reveals Conservation of Domain Structure, Multimerization, and Intracellular Storage , 2012, Advances in hematology.

[15]  G. Khandekar,et al.  Zebrafish Thrombocytes: Functions and Origins , 2012, Advances in hematology.

[16]  J. Keith Joung,et al.  Targeted gene disruption in somatic zebrafish cells using engineered TALENs , 2011, Nature Biotechnology.

[17]  L. Zon,et al.  Ubiquitous transgene expression and Cre-based recombination driven by the ubiquitin promoter in zebrafish , 2011, Development.

[18]  P. Jagadeeswaran,et al.  Zebrafish von Willebrand factor. , 2010, Blood cells, molecules & diseases.

[19]  R. Camire,et al.  The molecular basis of factor V and VIII procofactor activation , 2009, Journal of thrombosis and haemostasis : JTH.

[20]  K. Sadler,et al.  New school in liver development: Lessons from zebrafish , 2009, Hepatology.

[21]  F. Peyvandi,et al.  Factor V deficiency. , 2009, Seminars in thrombosis and hemostasis.

[22]  Jonathan E. Foley,et al.  Rapid Mutation of Endogenous Zebrafish Genes Using Zinc Finger Nucleases Made by Oligomerized Pool ENgineering (OPEN) , 2009, PloS one.

[23]  M. Koerper,et al.  Factor V deficiency: a concise review , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[24]  K. Kawakami,et al.  A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. , 2004, Developmental cell.

[25]  D. Dimichele,et al.  Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias , 2004, Journal of thrombosis and haemostasis : JTH.

[26]  E. Santagostino,et al.  Clinical and molecular characterization of 6 patients affected by severe deficiency of coagulation factor V: Broadening of the mutational spectrum of factor V gene and in vitro analysis of the newly identified missense mutations. , 2003, Blood.

[27]  G. Elgar,et al.  Molecular evolution of the vertebrate blood coagulation network , 2003, Thrombosis and Haemostasis.

[28]  P. Jagadeeswaran,et al.  Comprehensive analysis of blood coagulation pathways in teleostei: evolution of coagulation factor genes and identification of zebrafish factor VIIi. , 2002, Blood cells, molecules & diseases.

[29]  H. Yost,et al.  Cardiac morphology and blood pressure in the adult zebrafish , 2001, The Anatomical record.

[30]  D. Troyer,et al.  Demonstration of the extrinsic coagulation pathway in teleostei: Identification of zebrafish coagulation factor VII , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Saito,et al.  Complete antithrombin deficiency in mice results in embryonic lethality. , 2000, The Journal of clinical investigation.

[32]  H. Yost,et al.  Structure and function of the developing zebrafish heart , 2000, The Anatomical record.

[33]  D. Girelli,et al.  Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. , 2000, Blood.

[34]  P. Jagadeeswaran,et al.  Identification and characterization of zebrafish thrombocytes , 1999, British journal of haematology.

[35]  F. Peyvandi,et al.  Symptoms of inherited factor V deficiency in 35 Iranian patients , 1998, British journal of haematology.

[36]  P. Reitsma,et al.  Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V gene , 1998, British journal of haematology.

[37]  P. Jagadeeswaran,et al.  Developmental expression of thrombin in zebrafish embryos: a novel model to study hemostasis. , 1997, Blood cells, molecules & diseases.

[38]  D. Ginsburg,et al.  Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V , 1996, Nature.

[39]  C. Kimmel,et al.  Stages of embryonic development of the zebrafish , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[40]  L. Cripe,et al.  Structure of the gene for human coagulation factor V. , 1992, Biochemistry.

[41]  C. Guguen-Guillouzo,et al.  Expression of coagulation factor V gene by normal adult human hepatocytes in primary culture , 1991, British journal of haematology.

[42]  P. Majerus,et al.  Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line. , 1984, The Journal of clinical investigation.

[43]  K. Mann,et al.  Radioimmunoassay of factor V in human plasma and platelets. , 1982, Blood.

[44]  J. Shavit,et al.  Quantitative methods for studying hemostasis in zebrafish larvae. , 2016, Methods in cell biology.

[45]  J. Joung,et al.  Targeted Mutagenesis in Zebrafish Using CRISPR RNA-Guided Nucleases. , 2015, Methods in molecular biology.

[46]  J. Shavit,et al.  Hemophilias and Other Disorders of Hemostasis , 2014 .

[47]  J. Shavit,et al.  Chapter 73 – Hemophilias and Other Disorders of Hemostasis , 2013 .

[48]  Justin C. Fay,et al.  Identification of deleterious mutations within three human genomes. , 2009, Genome research.

[49]  B. Thisse,et al.  High-resolution in situ hybridization to whole-mount zebrafish embryos , 2007, Nature Protocols.

[50]  K. Mann,et al.  Factor V: a combination of Dr Jekyll and Mr Hyde. , 2003, Blood.

[51]  E. Santagostino,et al.  Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein. , 2003, Blood.

[52]  Flora Peyvandi,et al.  The Thrombogram in Rare Inherited Coagulation Disorders: Its Relation to Clinical Bleeding , 2002, Thrombosis and Haemostasis.

[53]  G. Mariani,et al.  A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the Italian population. , 2001, Haematologica.

[54]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[55]  K G Mann,et al.  How Much Factor V Is Enough? , 2000, Thrombosis and Haemostasis.

[56]  G. Hauptmann,et al.  Multicolor whole-mount in situ hybridization. , 2000, Methods in molecular biology.

[57]  D. Ginsburg,et al.  Rescue of Fatal Neonatal Hemorrhage in Factor V Deficient Mice by Low Level Transgene Expression , 2000, Thrombosis and Haemostasis.

[58]  D. Rimoin.  Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics , 1997 .